At €50.20, Is It Time To Put Vilmorin & Cie SA (EPA:RIN) On Your Watch List?

While Vilmorin & Cie SA (EPA:RIN) might not be the most widely known stock at the moment, it saw a decent share price growth in the teens level on the ENXTPA over the last few months. With many analysts covering the stock, we may expect any price-sensitive announcements have already been factored into the stock’s share price. But what if there is still an opportunity to buy? Let’s take a look at Vilmorin & Cie’s outlook and value based on the most recent financial data to see if the opportunity still exists.

View our latest analysis for Vilmorin & Cie

What is Vilmorin & Cie worth?

According to my valuation model, Vilmorin & Cie seems to be fairly priced at around 12% below my intrinsic value, which means if you buy Vilmorin & Cie today, you’d be paying a fair price for it. And if you believe the company’s true value is €57.13, then there isn’t much room for the share price grow beyond what it’s currently trading. What's more, Vilmorin & Cie’s share price may be more stable over time (relative to the market), as indicated by its low beta.

What does the future of Vilmorin & Cie look like?

Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Although value investors would argue that it’s the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. Vilmorin & Cie's earnings over the next few years are expected to increase by 65%, indicating a highly optimistic future ahead. This should lead to more robust cash flows, feeding into a higher share value.

What this means for you:

Are you a shareholder? It seems like the market has already priced in RIN’s positive outlook, with shares trading around its fair value. However, there are also other important factors which we haven’t considered today, such as the financial strength of the company. Have these factors changed since the last time you looked at the stock? Will you have enough conviction to buy should the price fluctuates below the true value?

Are you a potential investor? If you’ve been keeping an eye on RIN, now may not be the most optimal time to buy, given it is trading around its fair value. However, the optimistic prospect is encouraging for the company, which means it’s worth further examining other factors such as the strength of its balance sheet, in order to take advantage of the next price drop.

So while earnings quality is important, it's equally important to consider the risks facing Vilmorin & Cie at this point in time. While conducting our analysis, we found that Vilmorin & Cie has 2 warning signs and it would be unwise to ignore them.

If you are no longer interested in Vilmorin & Cie, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

If you’re looking to trade Vilmorin & Cie, open an account with the lowest-cost* platform trusted by professionals, Interactive Brokers. Their clients from over 200 countries and territories trade stocks, options, futures, forex, bonds and funds worldwide from a single integrated account. Promoted

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
^*Interactive Brokers Rated Lowest Cost Broker by StockBrokers.com Annual Online Review 2020

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.